[1] |
WHO. Coronavirus (COVID-19) Dashboard[EB/OL].[2022-02-05]. .
|
[2] |
WHO. Tracking SARS-CoV-2 variants[EB/OL].(2021-12-06) [2022-02-06]. .
|
[3] |
HE X,LAU E H Y,WU P,et al. Temporal dynamics in viral shedding and transmissibility of COVID-19[J]. Nat Med,2020,26(5):672-675. DOI:10.1038/s41591-020-0869-5.
|
[4] |
万时雨,刘珏,刘民. 新型冠状病毒肺炎潜伏期的研究进展[J]. 科学通报,2021,66(15):1802-1811.
|
[5] |
CHAN J F,KOK K H,ZHU Z,et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan[J]. Emerg Microbes Infect,2020,9(1):221-236. DOI:10.1080/22221751.2020.1719902.
|
[6] |
WU J T,LEUNG K,LEUNG G M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan,China:a modelling study[J]. Lancet,2020,395(10225):689-697. DOI:10.1016/S0140-6736(20)30260-9.
|
[7] |
GUAN W J,NI Z Y,HU Y,et al. Clinical characteristics of coronavirus disease 2019 in China[J]. N Engl J Med,2020,382(18):1708-1720. DOI:10.1056/nejmoa2002032.
|
[8] |
MEYEROWITZ E A,RICHTERMAN A,GANDHI R T,et al. Transmission of SARS-CoV-2:a review of viral,host,and environmental factors[J]. Ann Intern Med,2021,174(1):69-79. DOI:10.7326/M20-5008.
|
[9] |
LI Q,GUAN X H,WU P,et al. Early transmission dynamics in Wuhan,China,of novel coronavirus-infected pneumonia[J]. N Engl J Med,2020,382(13):1199-1207. DOI:10.1056/NEJMoa2001316.
|
[10] |
ZHANG J J,LITVINOVA M,WANG W,et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei Province,China:a descriptive and modelling study[J]. Lancet Infect Dis,2020,20(7):793-802. DOI:10.1016/S1473-3099(20)30230-9.
|
[11] |
HU S X,WANG W,WANG Y,et al. Infectivity,susceptibility,and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan,China[J]. Nat Commun,2021,12(1):1533. DOI:10.1038/s41467-021-21710-6.
|
[12] |
BACKER J A,KLINKENBERG D,WALLINGA J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan,China,20-28 January 2020[J]. Eurosurveillance,2020,25(5):2000062. DOI:10.2807/1560-7917.es.2020.25.5.2000062.
|
[13] |
LAUER S A,GRANTZ K H,BI Q F,et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases:estimation and application[J]. Ann Intern Med,2020,172(9):577-582. DOI:10.7326/M20-0504.
|
[14] |
YANG L,DAI J Y,ZHAO J,et al. Estimation of incubation period and serial interval of COVID-19:analysis of 178 cases and 131 transmission chains in Hubei Province,China[J]. Epidemiol Infect,2020,148:e117. DOI:10.1017/S0950268820001338.
|
[15] |
PATRIKAR S R,KOTWAL A,BHATTI V K,et al. Incubation period and reproduction number for novel coronavirus 2019 (COVID-19) infections in India[J]. Asia Pac J Public Health,2020,32(8):458-460. DOI:10.1177/1010539520956427.
|
[16] |
BÖHMER M M,BUCHHOLZ U,CORMAN V M,et al. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case:a case series[J]. Lancet Infect Dis,2020,20(8):920-928. DOI:10.1016/S1473-3099(20)30314-5.
|
[17] |
Public Health England. Investigation of SARS-CoV-2 variants of concern:technical briefings[EB/OL]. (2021-12-17) [2022-02-06]. .
|
[18] |
穆雪纯,李丽,王凌航. 新型冠状病毒流行变异株的分型及研究进展[J]. 国际病毒学杂志,2021,28(4):336-340. DOI:10.3760/cma.j.issn.1673-4092.2021.04.018.
|
[19] |
沈佳莹,林剑生,曹广文. 新型冠状病毒的变异株进展:起源、变异动力与防控措施[J]. 上海预防医学,2022,34(1):81-86. DOI:10.19428/j.cnki.sjpm.2022.21039.
|
[20] |
WHO. COVID-19 - Global[EB/OL]. (2020-12-31) [2022-02-06]. .
|
[21] |
GRANT R,CHARMET T,SCHAEFFER L,et al. Impact of SARS-CoV-2 Delta variant on incubation,transmission settings and vaccine effectiveness:results from a nationwide case-control study in France[J]. Lancet Reg Health Eur,2022,13:100278. DOI:10.1016/j.lanepe.2021.100278.
|
[22] |
HOMMA Y,KATSUTA T,OKA H,et al. The incubation period of the SARS-CoV-2 B1.1.7 variant is shorter than that of other strains[J]. J Infect,2021,83(2):e15-17. DOI:10.1016/j.jinf.2021.06.011.
|
[23] |
TEGALLY H,WILKINSON E,GIOVANETTI M,et al. Detection of a SARS-CoV-2 variant of concern in South Africa[J]. Nature,2021,592(7854):438-443. DOI:10.1038/s41586-021-03402-9.
|
[24] |
National Center for Immunization and Respiratory Diseases (NCIRD),Division of Viral Diseases. Science Brief:Emerging SARS-CoV-2 Variants[EB/OL].(2020-12-29)[2022-02-06]. .
|
[25] |
The SARS-CoV-2 Variant with Lineage B.1.351 Clusters Investigation Team. Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France,January 2021[J]. Eurosurveillance,2021,26(13):2100333. DOI:10.2807/1560-7917.es.2021.26.13.2100333.
|
[26] |
SINGH J,RAHMAN S A,EHTESHAM N Z,et al. SARS-CoV-2 variants of concern are emerging in India[J]. Nat Med,2021,27(7):1131-1133. DOI:10.1038/s41591-021-01397-4.
|
[27] |
杜敏,刘民,刘珏. 新型冠状病毒Delta变异株的流行病学特征及防控研究进展[J]. 中华流行病学杂志,2021,42(10):1774-1779. DOI:10.3760/cma.j.cn112338-20210808-00619.
|
[28] |
ZHANG M,XIAO J P,DENG A P,et al. Transmission dynamics of an outbreak of the COVID-19 delta variant B.1.617.2 - Guangdong Province,China,May-June 2021[J]. China CDC Wkly,2021,3(27):584-586. DOI:10.46234/ccdcw2021.148.
|
[29] |
WANG Y P,CHEN R C,HU F Y,et al. Transmission,viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou,China[J]. EClinicalMedicine,2021,40:101129. DOI:10.1016/j.eclinm.2021.101129.
|
[30] |
卓家同. Delta变异株超短偷袭与超长逃逸及其防控——以真实案例探讨新型冠状病毒传播的预防与阻击[J]. 上海预防医学,2021,33(9):869-874. DOI:10.19428/j.cnki.sjpm.2021.21235.
|
[31] |
JANSEN L,TEGOMOH B,LANGE,et al. Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) variant cluster - Nebraska,November-December 2021[J]. MMWR Morb Mortal Wkly Rep,2021,70(5152):1782-1784. DOI:10.15585/mmwr.mm705152e3.
|
[32] |
BRANDAL L T,MACDONALD E,VENETI L,et al. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway,November to December 2021[J]. Eur Commun Dis Bull,2021,26(50):2101147. DOI:10.2807/1560-7917.ES.2021.26.50.2101147.
|
[33] |
LEE J J,CHOE Y J,JEONG H,et al. Importation and transmission of SARS-CoV-2 B.1.1.529 (Omicron) variant of concern in Korea,November 2021[J]. J Korean Med Sci,2021,36(50):e346. DOI:10.3346/jkms.2021.36.e346.
|